ACS Medicinal Chemistry Letters · 2011 · 92 citations · 17 references
PharmacyMedicinal ChemistryPharmacologyBioisosterismDrug DiscoveryOrganometallic ChemistryEnzyme InhibitionMolecular DockingStructure-activity Relationship AnalysisAnticancer ActivityAnticancer Mechanism Of ActionBiological Evaluation ReportHistone DeacetylasesMedicinal Chemistry ApplicationsMolecular Docking Of InhibitorsOrganometallic ComplexesSelectivity
N(1)-Hydroxy-N(8)-ferrocenyloctanediamide, JAHA (7), an organometallic analogue of SAHA containing a ferrocenyl group as a phenyl bioisostere, displays nanomolar inhibition of class I HDACs, excellent selectivity over class IIa HDACs, and anticancer action in intact cells (IC(50) = 2.4 μM, MCF7 cell line). Molecular docking studies of 7 in HDAC8 (a,b) suggested that the ferrocenyl moiety in 7 can overlap with the aryl cap of SAHA and should display similar HDAC inhibition, which was borne out in an in vitro assay (IC(50) values against HDAC8 (μM, SD in parentheses): SAHA, 1.41 (0.15); 7, 1.36 (0.16). Thereafter, a small library of related JAHA analogues has been synthesized, and preliminary SAR studies are presented. IC(50) values as low as 90 pM toward HDAC6 (class IIb) have been determined, highlighting the excellent potential of JAHAs as bioinorganic probes.
17
Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
Chunaram Choudhary, Chanchal Kumar, Florian Gnad et al. · Science · 2009 · 4K citations · Full text
Chemical phylogenetics of histone deacetylases
James E. Bradner, Nathan West, Melissa L. Grachan et al. · Nature Chemical Biology · 2010 · 728 citations · Full text
Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases
John R. Somoza, R.J. Skene, B.A. Katz et al. · Structure · 2004 · 698 citations · Full text